Abstract
Levels of misonidazole in human tumours, normal tissues and blood have been measured in patients given a 1g oral dose of drug before surgery or biopsy. The results show that 50--70% of the blood level was found in a wide range of tumours and that similar levels were found in adjacent normal tissues. Good penetration of drug was achieved within tumours, and up to 90--100% of the blood level was found in the necrotic cyst fluid at the centre of some tumours. CSF studies showed free diffusion into the CNS, which was confirmed by finding 50--70% of the blood level within brain tumours. A delay of passage of drugs into the CSF was noted, which was not found for drug diffusion into bile and saliva.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Ash, D., Smith, M. & Bugden, R. Distribution of misonidazole in human tumours and normal tissues. Br J Cancer 39, 503–509 (1979). https://doi.org/10.1038/bjc.1979.93
Issue Date:
DOI: https://doi.org/10.1038/bjc.1979.93
This article is cited by
-
Misonidazole combined with photodynamic therapy of rat 9L gliosarcoma tumours
Lasers in Medical Science (1989)
-
Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors
Cancer Chemotherapy and Pharmacology (1987)
-
Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography
Cancer Chemotherapy and Pharmacology (1986)
-
Sensitizers as an adjunct in the treatment of bladder cancer
World Journal of Urology (1985)